Default: Clinical Pharmacokinetics

ISSN: 0312-5963

Journal Home

Journal Guideline

Clinical Pharmacokinetics Q1 Unclaimed

Adis International Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Pharmacokinetics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 176. It has a price of 3290 €. It has an SJR impact factor of 1,238 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,238.

Clinical Pharmacokinetics focuses its scope in these topics and keywords: pharmacokinetics, pharmacodynamics, subjects, gastrointestinal, folic, healthy, ideal, ii, interactions, intramuscular, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


3290 €

Inmediate OA


Embargoed OA

0 €

Non OA


Clinical Pharmacokinetics


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

pharmacokinetics, pharmacodynamics, subjects, gastrointestinal, folic, healthy, ideal, ii, interactions, intramuscular, lmethyltetrahydrofolateclinical, metoprololpharmacokinetic, nonantiretroviral, oral, organ, absorption, palmitate, patients, abiraterone, cpdrug, acid, analyses, arthritis, aspects, blood, cancer, castrationresistant, clinical, acetate, cypa, disease, dried, drugs, drugsphase, enzalutamide, etravirine,

Best articles by citations

Pharmacokinetic Individualisation of Zidovudine Therapy

View more

A Retrospective Analysis of Pharmacokinetic-Pharmacodynamic Parameters as Indicators of the Clinical Efficacy of Ceftizoxime

View more

Pharmacokinetic Interactions of Antimalarial Agents

View more

Population Pharmacokinetics of??Levetiracetam in Japanese and??Western Adults

View more

Effect of Rifampicin on the Pharmacokinetics of Fluconazole in Patients with AIDS

View more

Pharmacokinetic Optimisation in the Treatment of Gastro-Oesophageal Reflux Disease

View more

Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic Considerations

View more

Pharmacokinetic Optimisation of Antibacterial Treatment in Patients with Cystic Fibrosis

View more

Intracellular Concentrations of Antibacterial Agents and Related Clinical Implications

View more

Pharmacokinetic Optimisation of Oral Antifungal Therapy

View more

Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine

View more

Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections

View more

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism

View more

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

View more

Application of a Gamma Model of Absorption to Oral Cyclosporin

View more

Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients

View more

Evaluation of Pharmacokinetic Interactions After Oral Administration of Mycophenolate Mofetil and Valaciclovir or Aciclovir to Healthy Subjects

View more

Relationship Between Minimum Inhibitory Concentration and Stationary Concentration Revisited

View more

Pharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling Strategies

View more

Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

View more

Osmotherapy for Elevated Intracranial Pressure

View more

Dosage Adjustments for Antibacterials in Obese Patients

View more

Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients

View more

Comparative Pharmacokinetics and Pharmacodynamics of the Newer Fluoroquinolone Antibacterials

View more